Novartis Biome Singapore: a digital innovation hub for startups and collaborators
Novartis Biome Singapore is a launchpad for digital innovation in the region, fostering conversations on digital healthcare and deepening engagement between Novartis, the healthcare ecosystem and innovation community in Asia.
Feb 26, 2021
At Novartis, we believe in uniting the best of science and technology to create better healthcare solutions and seamless experiences for patients and caregivers, at scale. We aspire to create impactful change in the healthcare space with solutions that are effective in addressing patient concerns. In our pursuit of healthcare excellence, we look towards digital solutions to provide better healthcare solutions and seamless experiences at scale.
With the second highest concentration of digital health ventures in Asia Pacific, and more than half of Southeast Asia’s health-tech investments, Singapore has become a viable location for the region’s most promising digital health ventures. As a global healthcare company, we have a great pool of resources to offer, from data sandboxes with 2 million patient years of data, expertise from functions such as regulatory, medical, clinical trial design, market access and legal, customized residency programs and mentors.
A catalyst for impactful digital collaboration
Biome Singapore is Novartis’ first innovation hub for the Asia Pacific Middle East and Africa region dedicated to driving and managing partnerships with digital health startups, innovators and thought leaders in healthcare transformation.Novartis Biome Singapore is the latest inclusion of the global Biome network, following launches in San Francisco (USA), London (UK), Paris (France), Hyderabad (India), Montreal (Canada), Shanghai (China) and Berlin (Germany).
“We are thrilled to have Biome Singapore be part of the Novartis Biome network. This digital innovation lab presents as an excellent opportunity to establish great collaborations and lead in the innovation of digital solutions that can help transform the healthcare landscape in Singapore and beyond,” said Kevin Zou, Country President of Novartis Singapore.
Kevin Zou, Country President of Novartis Singapore giving the opening address at the Digital Health Innovation Forum.
Biome Singapore will connect Novartis teams to the external digital ecosystem, allowing them to identify, establish and build on strong collaborations that produce significantly innovative and scalable solutions for patients. Similarly, partners who join this global network have access to an array of assets and expertise from the wider Novartis portfolio, to bring transformative impact.
One example of collaboration is the Biome Fellowship Program, a six-month incubation program offered to the best-in-class ventures to accelerate their early-stage growth. Participants of the program will not only benefit from the mentorship from Novartis experts to scale their business globally but may also receive attractive partnership opportunities to co-develop digital health solutions with Novartis business units.
Fostering conversations around digital healthcare
On 26 February 2021, Novartis Singapore launched the inaugural Digital Health Innovation Forum, a platform to foster conversations on digital healthcare and deepen engagement between Novartis, the healthcare system, and innovation community.
The hybrid physical-virtual event was held at the Novartis Singapore Biome Digital Innovation Hub and broadcasted to a live audience via web conference. Beginning with a series of discussion panels and keynote speeches from different healthcare innovation perspectives, the event concluded with tours of the Biome digital innovation lab and showcases from Novartis’ start-up partners.
Keynote address by Terrence Ng, Director, Policy & Technology Innovation Office, Singapore Health Promotion Board
The guest speaker line up consisted of Professor. Robert Morris, Chief Technology Strategist, MOH Office for Healthcare Transformation, Terrence Ng, Director, Policy & Technology Innovation Office, Health Promotion Board, Dr. Daniel Ting, Head of AIand Digital Innovation in Singapore Eye Research Institute (SERI), Kuldeep Singh Rajput, Founder & CEO, Biofourmis, sharing their expert insights in the digital healthcare space, and how different stakeholders are boosting innovation in the Singapore ecosystem.
Left to right: Goh Wan Yee, Senior Vice President and Head of Healthcare EDB, Kuntal Baveja, Head of Commercial Operations Asia Pacific, Professor Robert Morris, Chief Technology Strategist of MOH Office for Healthcare Transformation.
Left to right: Dr. Daniel Ting, Head of AI and Digital Innovation in Singapore Eye Research Institute (SERI), Kuldeep Singh Rajput, Founder & CEO, Biofourmis, Alexis Serlin, Head of Novartis Asia Cluster, Helena Champoux, COO Galen Growth Asia
Christian Teo, Head of Novartis Biome Singapore, said, “With dedicated startups and innovators playing a crucial role in the digital evolution of the healthcare ecosystem, Biome Singapore presents an excellent opportunity for changemakers in the industry to work with us and utilize the Biome’s comprehensive capabilities to produce impactful digital solutions for patients.”
Christian Teo, Head of Novartis Biome Singapore
The Digital Health Innovation Forum kickstarted Novartis Biome’s commitment to house more dialogue and perspective on digital health. We hope to host many more similar events in the future, engaging conversation on forward looking perspectives in healthcare.
For questions about the Novartis Biome, please contact our team at: [email protected]